Chris Israel, the Executive Director of the Alliance of U.S. Startups and Inventors for Jobs (USIJ), wrote a letter on behalf of USIJ to Senate Judiciary Chairman Dick Durbin and Ranking Member Lindsey Graham regarding today’s hearing - Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market. The letter expresses firm support for a strong and secure patent system and debunks harmful myths and misperceptions.

“Patients need innovative new drugs. And the development of those new drugs depends heavily on secure intellectual property protections. During your deliberations, we urge you to keep in mind the critical importance of these protections.”